Citadel Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.07M | Sell |
274,574
-504,921
| -65% | -$7.38M | ﹤0.01% | 4682 |
|
|
2025
Q4 | $12.4M | Buy |
779,495
+76,840
| +11% | +$1.09M | ﹤0.01% | 2968 |
|
|
2025
Q3 | $7.76M | Buy |
702,655
+585,018
| +497% | +$6.39M | ﹤0.01% | 3623 |
|
|
2025
Q2 | $996K | Sell |
117,637
-3,340
| -3% | -$26.8K | ﹤0.01% | 7092 |
|
|
2025
Q1 | $973K | Sell |
120,977
-47,525
| -28% | -$385K | ﹤0.01% | 7021 |
|
|
2024
Q4 | $1.51M | Sell |
168,502
-378,370
| -69% | -$3.09M | ﹤0.01% | 6207 |
|
|
2024
Q3 | $4.01M | Sell |
546,872
-390,920
| -42% | -$2.42M | ﹤0.01% | 4308 |
|
|
2024
Q2 | $5.35M | Buy |
937,792
+669,389
| +249% | +$3.53M | ﹤0.01% | 3635 |
|
|
2024
Q1 | $1.34M | Sell |
268,403
-310,262
| -54% | -$2.1M | ﹤0.01% | 6322 |
|
|
2023
Q4 | $5.2M | Sell |
578,665
-59,239
| -9% | -$488K | ﹤0.01% | 3723 |
|
|
2023
Q3 | $4.96M | Buy |
637,904
+275,906
| +76% | +$2.7M | ﹤0.01% | 3655 |
|
|
2023
Q2 | $3.5M | Sell |
361,998
-2,085,275
| -85% | -$21.6M | ﹤0.01% | 4194 |
|
|
2023
Q1 | $26.8M | Sell |
2,447,273
-1,329,989
| -35% | -$11.7M | 0.01% | 1635 |
|
|
2022
Q4 | $16.3M | Buy |
3,777,262
+1,027,146
| +37% | +$5.96M | ﹤0.01% | 2184 |
|
|
2022
Q3 | $20.7M | Buy |
2,750,116
+1,880,872
| +216% | +$16.3M | ﹤0.01% | 1840 |
|
|
2022
Q2 | $8.74M | Sell |
869,244
-279,902
| -24% | -$3.13M | ﹤0.01% | 2867 |
|
|
2022
Q1 | $14.2M | Buy |
1,149,146
+431,853
| +60% | +$6.67M | ﹤0.01% | 2434 |
|
|
2021
Q4 | $16.4M | Buy |
717,293
+96,960
| +16% | +$2.3M | ﹤0.01% | 2282 |
|
|
2021
Q3 | $13.7M | Sell |
620,333
-84,962
| -12% | -$1.35M | ﹤0.01% | 2566 |
|
|
2021
Q2 | $9.14M | Sell |
705,295
-727,898
| -51% | -$9.27M | ﹤0.01% | 3217 |
|
|
2021
Q1 | $18.6M | Sell |
1,433,193
-40,855
| -3% | -$593K | ﹤0.01% | 2064 |
|
|
2020
Q4 | $20.4M | Sell |
1,474,048
-2,004,162
| -58% | -$29.2M | 0.01% | 1780 |
|
|
2020
Q3 | $51.2M | Buy |
3,478,210
+2,578,478
| +287% | +$37.4M | 0.01% | 842 |
|
|
2020
Q2 | $14.6M | Sell |
899,732
-358,654
| -29% | -$5.74M | 0.01% | 1805 |
|
|
2020
Q1 | $18.3M | Buy |
1,258,386
+320,895
| +34% | +$5.66M | 0.01% | 1311 |
|
|
2019
Q4 | $19M | Buy |
937,491
+882,480
| +1,604% | +$8.13M | 0.01% | 1534 |
|
|
2019
Q3 | $294K | Sell |
55,011
-46,036
| -46% | -$279K | ﹤0.01% | 7583 |
|
|
2019
Q2 | $665K | Sell |
101,047
-35,474
| -26% | -$226K | ﹤0.01% | 6360 |
|
|
2019
Q1 | $887K | Buy |
136,521
+20,363
| +18% | +$135K | ﹤0.01% | 5800 |
|
|
2018
Q4 | $792K | Sell |
116,158
-20,029
| -15% | -$115K | ﹤0.01% | 5668 |
|
|
2018
Q3 | $904K | Buy |
+136,187
| New | +$764K | ﹤0.01% | 5719 |
|
|
2018
Q2 | – | Sell |
-50,922
| Closed | -$284K | – | 8796 |
|
|
2018
Q1 | $264K | Sell |
50,922
-76,367
| -60% | -$409K | ﹤0.01% | 6931 |
|
|
2017
Q4 | $577K | Buy |
127,289
+115,389
| +970% | +$641K | ﹤0.01% | 5429 |
|
|
2017
Q3 | $75K | Sell |
11,900
-61,370
| -84% | -$387K | ﹤0.01% | 7106 |
|
|
2017
Q2 | $449K | Sell |
73,270
-95,933
| -57% | -$646K | ﹤0.01% | 5269 |
|
|
2017
Q1 | $1.24M | Buy |
+169,203
| New | +$782K | ﹤0.01% | 3694 |
|
|
2016
Q4 | – | Sell |
-15,236
| Closed | -$46K | – | 7232 |
|
|
2016
Q3 | $46K | Buy |
+15,236
| New | +$41.1K | ﹤0.01% | 6871 |
|
Other funds holding AUPH
TCM
NMC
